360 related articles for article (PubMed ID: 21502240)
1. The Vaccine Safety Datalink: a model for monitoring immunization safety.
Baggs J; Gee J; Lewis E; Fowler G; Benson P; Lieu T; Naleway A; Klein NP; Baxter R; Belongia E; Glanz J; Hambidge SJ; Jacobsen SJ; Jackson L; Nordin J; Weintraub E
Pediatrics; 2011 May; 127 Suppl 1():S45-53. PubMed ID: 21502240
[TBL] [Abstract][Full Text] [Related]
2. The Vaccine Safety Datalink project.
DeStefano F;
Pharmacoepidemiol Drug Saf; 2001; 10(5):403-6. PubMed ID: 11802585
[TBL] [Abstract][Full Text] [Related]
3. The Vaccine Safety Datalink: immunization research in health maintenance organizations in the USA.
Chen RT; DeStefano F; Davis RL; Jackson LA; Thompson RS; Mullooly JP; Black SB; Shinefield HR; Vadheim CM; Ward JI; Marcy SM
Bull World Health Organ; 2000; 78(2):186-94. PubMed ID: 10743283
[TBL] [Abstract][Full Text] [Related]
4. Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network.
LaRussa PS; Edwards KM; Dekker CL; Klein NP; Halsey NA; Marchant C; Baxter R; Engler RJ; Kissner J; Slade BA
Pediatrics; 2011 May; 127 Suppl 1():S65-73. PubMed ID: 21502239
[TBL] [Abstract][Full Text] [Related]
5. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
[TBL] [Abstract][Full Text] [Related]
6. The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety.
McNeil MM; Gee J; Weintraub ES; Belongia EA; Lee GM; Glanz JM; Nordin JD; Klein NP; Baxter R; Naleway AL; Jackson LA; Omer SB; Jacobsen SJ; DeStefano F
Vaccine; 2014 Sep; 32(42):5390-8. PubMed ID: 25108215
[TBL] [Abstract][Full Text] [Related]
7. Ensuring the optimal safety of licensed vaccines: a perspective of the vaccine research, development, and manufacturing companies.
Kanesa-thasan N; Shaw A; Stoddard JJ; Vernon TM
Pediatrics; 2011 May; 127 Suppl 1():S16-22. PubMed ID: 21502248
[TBL] [Abstract][Full Text] [Related]
8. Vaccinovigilance in Europe--need for timeliness, standardization and resources.
Lankinen KS; Pastila S; Kilpi T; Nohynek H; Mäkelä PH; Olin P
Bull World Health Organ; 2004 Nov; 82(11):828-35. PubMed ID: 15640918
[TBL] [Abstract][Full Text] [Related]
9. Monitoring vaccine safety using the Vaccine Safety Datalink: utilizing immunization registries for pandemic influenza.
McCarthy NL; Gee J; Weintraub E; Donahue JG; Nordin JD; Daley MF; Naleway A; Henninger M; Baxter R; Crane B; Aukes L; Wagner N; Fisher S; Jacobsen SJ; Sy L; Baggs J
Vaccine; 2011 Jul; 29(31):4891-6. PubMed ID: 21596088
[TBL] [Abstract][Full Text] [Related]
10. Safety monitoring in vaccine development and immunization.
Lee CJ; Lee LH; Lu CH; Huang YJ; Chu ML
Acta Paediatr Taiwan; 2006; 47(1):7-13. PubMed ID: 17016963
[TBL] [Abstract][Full Text] [Related]
11. Active surveillance for adverse events: the experience of the Vaccine Safety Datalink project.
Yih WK; Kulldorff M; Fireman BH; Shui IM; Lewis EM; Klein NP; Baggs J; Weintraub ES; Belongia EA; Naleway A; Gee J; Platt R; Lieu TA
Pediatrics; 2011 May; 127 Suppl 1():S54-64. PubMed ID: 21502252
[TBL] [Abstract][Full Text] [Related]
12. Combination vaccines: postlicensure safety evaluation.
Chen RT; Pool V; Takahashi H; Weniger BG; Patel B
Clin Infect Dis; 2001 Dec; 33 Suppl 4():S327-33. PubMed ID: 11709768
[TBL] [Abstract][Full Text] [Related]
13. Near real-time vaccine safety surveillance with partially accrued data.
Greene SK; Kulldorff M; Yin R; Yih WK; Lieu TA; Weintraub ES; Lee GM
Pharmacoepidemiol Drug Saf; 2011 Jun; 20(6):583-90. PubMed ID: 21538670
[TBL] [Abstract][Full Text] [Related]
14. [Essential to monitor vaccine safety].
Heijbel H
Lakartidningen; 2001 Sep; 98(36):3777-8. PubMed ID: 11586806
[TBL] [Abstract][Full Text] [Related]
15. Monitoring and assessing vaccine safety: a European perspective.
Lopalco PL; Johansen K; Ciancio B; De Carvalho Gomes H; Kramarz P; Giesecke J
Expert Rev Vaccines; 2010 Apr; 9(4):371-80. PubMed ID: 20370548
[TBL] [Abstract][Full Text] [Related]
16. Guillain-Barré syndrome after vaccination in United States: data from the Centers for Disease Control and Prevention/Food and Drug Administration Vaccine Adverse Event Reporting System (1990-2005).
Souayah N; Nasar A; Suri MF; Qureshi AI
J Clin Neuromuscul Dis; 2009 Sep; 11(1):1-6. PubMed ID: 19730016
[TBL] [Abstract][Full Text] [Related]
17. The Food and Drug Administration's Post-Licensure Rapid Immunization Safety Monitoring program: strengthening the federal vaccine safety enterprise.
Nguyen M; Ball R; Midthun K; Lieu TA
Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():291-7. PubMed ID: 22262619
[TBL] [Abstract][Full Text] [Related]
18. Monitoring vaccine safety during an influenza pandemic.
Iskander J; Haber P; Herrera G
Yale J Biol Med; 2005 Oct; 78(5):265-75. PubMed ID: 17132333
[TBL] [Abstract][Full Text] [Related]
19. Statistical, epidemiological, and risk-assessment approaches to evaluating safety of vaccines throughout the life cycle at the Food and Drug Administration.
Ball R; Horne D; Izurieta H; Sutherland A; Walderhaug M; Hsu H
Pediatrics; 2011 May; 127 Suppl 1():S31-8. PubMed ID: 21502249
[TBL] [Abstract][Full Text] [Related]
20. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
